Dror Ortho-Design Reports Q2 2026 Financial Results with $625K Net Loss

Dror Ortho-Design, Inc. reported its financial results for the second quarter of 2026, revealing a net loss of $625,143, a decrease from the $759,338 loss recorded in the same period of 2025. For the six months ending June 30, 2026, the company reported a net loss of $1,263,809, compared to a loss of $1,335,461 for the first half of 2025. The company's total operating expenses for the second quarter were $495,766, down 32% from $731,539 in the prior year, primarily due to reduced research and development costs, which fell by 53% to $150,769.

The company’s balance sheet as of June 30, 2026, showed total assets of $365,689, an increase from $258,936 at the end of 2025. Current liabilities surged to $4,100,088, up from $2,956,554, largely due to an increase in accrued expenses and convertible promissory notes. The stockholders' deficit also widened to $3,937,520 from $2,873,711, reflecting the ongoing operational losses and the company's reliance on external financing.

Strategically, Dror Ortho-Design has focused on developing its proprietary orthodontic alignment platform, which is currently in the research and development phase. The company has not yet generated revenue and is preparing for a new 510(k) submission to the FDA for its updated platform. The company’s cash position decreased to $93,563 from $228,540 at the end of 2025, indicating a need for additional capital to sustain operations. During the first half of 2026, the company raised $575,000 through bridge loans, compared to $500,000 in the same period of 2025.

Operationally, the company has not reported significant changes in customer counts or user statistics, as it remains in the development stage without commercial sales. The company’s employee headcount has not been disclosed, but it continues to manage costs amid ongoing losses. The management has expressed concerns regarding its ability to continue as a going concern, emphasizing the need for additional funding to support its operations and development efforts.

Looking ahead, Dror Ortho-Design anticipates continued losses as it invests in the development of its platform and seeks regulatory approvals. The company plans to allocate approximately $1.5 million over the next 18 months for software and hardware development, as well as intellectual property protection. However, the management has cautioned that there is no assurance of successful fundraising or market acceptance of its products, which could significantly impact its future operations and financial stability.